QB3 Bioentrepreneurship Podcast
Summary: Leading entrepreneurs, venture capitalists, and industry experts share insights on launching and running a successful bioscience startup. Regular episodes are recorded at a seminar series hosted by The California Institute for Quantitative Biosciences (QB3). QB3 is a nonprofit institute spanning three University of California campuses in the San Francisco Bay Area: UCSF, UC Berkeley, and UC Santa Cruz. We help life science researchers launch companies, forge alliances between industry and academia, and catalyze innovation in the California biotech ecosystem.
Podcasts:
The executive director of Breakout Labs talks about alternative funding models for startups. Podcast: Download: QB3 Lindy Fishburne.mp3
Timothy Gardner of Amyris talks about his role in the history of synthetic biology, and his experience with startups. Podcast: Download: Timothy Gardner QED.mp3
Christine McCaull, a 20 year tech start up veteran, leads a conversation on the commercial elements of bringing an idea forward and obtaining market success. Podcast: Download: QB3Podcast20120712_2.mp3
Dr. David Kirn, founder, president & CMO of Jennerex Biotherapeutics, talks about the development and clinical proof-of-concept of oncolytic viruses for cancer treatment. Podcast: Download: QB3Podcast20120706_13.mp3
Presented at the symposium “If only I'd known about preclinical drug development,” hosted by QB3 and co-sponsored by Patheon and Deloitte Consulting LLP. PDF: QB3Podcast20120702_12.pdf
Presented at the symposium “If only I'd known about preclinical drug development,” hosted by QB3 and co-sponsored by Patheon and Deloitte Consulting LLP. PDF: QB3Podcast20120702_11.pdf
Presented at the symposium “If only I'd known about preclinical drug development,” hosted by QB3 and co-sponsored by Patheon and Deloitte Consulting LLP. PDF: QB3Podcast20120702_10.pdf
Dr. Joseph Snyder is a Managing Partner of the international law firm Kilpatrick Townsend & Stockton. He explains the Supreme Court’s landmark Prometheus v. Mayo decision, and discusses its implications on patent eligible subject matter in biotech. PDF: QB3Podcast20120614_9.pdf
Dr. Joseph Snyder is a Managing Partner of the international law firm Kilpatrick Townsend & Stockton. He explains the Supreme Court’s landmark Prometheus v. Mayo decision, and discusses its profound implications on patent eligible subject matter in biotech. Podcast: Download: Joseph Snyder (Kilpatrick Townsend)
Dr. Lila Hope is a partner in the Life Sciences practice group at the international law firm Cooley. She advises startup companies on key elements in securing licenses to the technology and entering into research collaboration with other partners. PDF: QB3Podcast20120529_8.pdf
Dr. Lila Hope is a partner in the Life Sciences practice group at the international law firm Cooley. She advises startup companies on key elements in securing licenses to the technology and entering into research collaboration with other partners. Podcast: Download: Lila Hope (Cooley LLP)
Dr. Stephen Sherwin is the co-founder and chairman of Ceregene, and a Clinical Professor of Medicine at UCSF. He discusses the challenges faced by biotech startups, based on his three decades of experience. Podcast: Download: Stephen Sherwin (Ceregene & UCSF)